2 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Vernacare Product Managers To Lead The Vernacare Brand To New Heights
Congratulations to STEVE HOWELL from WA who is now taking on the responsibility of Vernacare Business Development Specialist for South Australia, Western Australia and Northern Territories.
Steve has worked tirelessly as Key Account Manager for Infection Prevention in WA over the past five years to grow the Vernacare brand, and its success is a significant factor in the current warehousing development we have just completed in WA (with the opening of the new EBOS warehouse in Canning Vale, Perth).
In 2008 Steven started at EBOS Healthcare as Key Account Manager for Hospitals and Aged Care in WA. He then joined the newly created Infection Prevention Division in 2011, focusing on hospitals and the Vernacare and Eschmann business in WA. This responsibility and significant learning experience led to a major shift in infection prevention thinking in WA.
In his new role as Vernacare Business Development Specialist for WA, SA and NT Steven will oversee all Verancare business in both hospitals and aged care in his territories, where major projects such as the Fiona Stanley and the new Royal Adelaide Hospitals are under way – and he will support and train the Infection Prevention Key Account Managers in these states. Steven will be managing these new responsibilities in conjunction with his continuing role as Key Account Manager for Hospitals in WA.
A warm welcome back to Alex MacKelden
Alex has been appointed Vernacare Product Manager for Queensland, Tasmania, New South Wales and Victoria within the Infection Prevention and Aged Care Divisions.
Alex is not a new face at EBOS as he was a prominent figure with the Infection Prevention and Hospital team based in Tasmania with Tasmed 2 years ago.
Alex says that being back at EBOS is great and he is looking forward to his new role as Product Manager for Vernacare, where he will work alongisde the Account Managers in QLD, TAS, NSW and Victoria supporting them with all opportunities related to the Vernacare business.
A big part of the role will also be on educating our customers and staff on the Vernacare system and rolling out sales and brand stratagies for our Infection Prevention and Aged Care sales teams.
Welcome to the Infection Prevention Team — Tom Hecimovic
Tom is the dedicated Account Manager for the Infection Prevention Division in Melbourne and VIC North West region. Prior to commencing with EBOS in October 2012, Tom spent several years in the pharmaceutical sales industry.
In his new role with EBOS Tom’s primary focus is to educate his Victorian customers on the advantages of using the Vernacare system, Tuffie 5 disinfectant wipes and Cutan hand sanitizers to help prevent the spread of infections in hospital environment. Tom is extremely passionate about his role with the Infection Prevention Team and prides himself on his professionalism and product knowledge.
LATEST NEWS FROM EBOS
2 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 3
HEALTHLINES ISSUE #4
EBOS WAREHOUSE EXPANSIONIt is official, EBOS Healthcare now has its own warehouse in Perth. The new operation is located in Canning Vale and our Western Australian team has just finished fitting out the new warehouse with racking, shelving, office furniture and everything else required to get our warehouse and office complete. The Perth warehouse is now fully operational and ready to fullfill all of our Western Australian customers requirements.Greg Cowlishaw, National Operations Manager for EBOS, says: “We had a very tight timeline with a great deal to do, but it was definitely worth the effort. This is another important step in EBOS consolidating and building towards our now complete national presence. It is great to see the investment in the business for Perth, but also in our Sydney warehouse where we are well under way with a large warehouse upgrade, in Brisbane where we have begun more work to create more space and efficiency, and in Melbourne, where we will see the biggest change and investment to any of our current warehouses since I started at EBOS back in 1996. I am confident that our national expansion and significant capital investment and upgrades will place EBOS in the best position possible to take our customer service and order delivery to a whole new level”.
Karen Amosa — Customer Service (Hospital And Aged Care)
Welcome to Karen Amosa, member of the EBOS Customer Service Team dedicated to our Infection Prevention and Aged Care Divisions. Prior to joining EBOS Karen worked in a number of Banking Customer Service and Support roles.
Karen supports our Hospital and Aged Care customers together with our experienced Amelia Lea (Amelia has been with EBOS for over 8 years and has a great knowledge of our products and hospital/aged care customers’ needs).
EBOS is now corporate member of the following Associations:
Association of Hospital Supply & Purchasing Officers Purchasing Officers.
Australian Association for the Manual Handling of People.
HIGHEST
SALES
EBOS Healthcare, sole Australian distributor for Eschmann equipment, received the coveted sales award in recognition for highest sales at an Asia Pacific Distributor meeting held in Bangkok, Thailand 10-13 April 2013.
Sales results of Eschmann operating tables, table accessories and clinical lighting 2011-2013 nationally resulted in the highest recorded result in Australian history.
Andrew McCullum, National Sales Manager for Hospital Division proudly accepted the award on behalf of EBOS Healthcare.
Eschmann Sales Award for EBOS HealthcareLATEST NEWS FROM EBOS
Left to right: Kylie Upton, Shahzad Shokrollahi, Andrew McCullum, Phillip Kennedy
Amelia (left) and Karen (right)
4 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Product Range Guide
MEDIHONEY® ANTIBACTERIAL MEDICAL HONEY
MEDIHONEY® WOUND GEL
MEDIHONEY® TULLE
MEDIHONEY® GEL SHEET
MEDIHONEY® ALGINATE
MEDIHONEY® HCS
Percentage of Medihoney
100% 80% 100% 80% 95% 63%
Absorbency N/A N/A
Nil. Allows fluid to pass through open weave into secondary absorbent dressing
Minimal to moderate
Moderate to heavy
Minimal to moderate
Ideally suited to/benefits
� Cavity or sinus wounds
� Internal applications
� Ophthalmic use � Wound debrider
for sloughy or necrotic tissue. Very cost effective compared to hydrogels because of long open shelf life
� Wound debrider for sloughy or necrotic tissue. Very cost effective compared to hydrogels because of long open shelf life.
� General wounds. A better formulation for general wound care than Medical Honey because it does not ‘run’. Exit sites
� Skin grafts � Whole limbs.
Can be unfolded to 30cm x 10cm size for applying to a limb. (Add extra Medical Honey if unfolded).
� Conforming around toes/fingers
� Superficial or partial thickness wounds
� People report less stinging with Gel Sheet than other honey dressings. Good for painful wounds
� Leg ulcers � Pressure ulcers � Fungating
wounds � Very wet cavity
wounds
� Minor burns � Post Op wounds � Large grazes � Superficial/
partial thickness wounds
Open shelf life
Once open, use within 4 months
Once open, use within 4 months
Single use only Single use only Single use only Single use only
[Effective on a variety of etiologies]
helping to make wound
management easier
MEDIHONEY® on left, plain alginate on right WK #3 after initiation of MEDIHONEY®
Steven J. Kavros, DPM: Case #1 of 3 presented at 2008 SAWC
Patient history of Crohn’s disease
Two wounds were both managed with systemic steroids, light compression to reduce edema and either plain alginate, or MEDIHONEY® alginate
MEDIHONEY
®
initiated
By WK #2, the wound managed with MEDIHONEY® was reduced by 62%
By WK #3, the wound managed with MEDIHONEY® healed, and the other wound is switched to MEDIHONEY® (heals at WK #4)
Peripheral neuropathy, ESRD, and CCL I
Dense fibrin tissue, slough and limited granulation tissue upon initial presentation
MEDIHONEY
®
initiated
Dressing changes every other day
Wound volume reduced by 25% by WK #4, and by 85% by WK #8. Complete healing by WK #16
Pyoderma
Gangrenosum
Recalcitrant
Diabetic Foot Ulcer
Catherine T. Milne, APRN, MSN, CWOCN: Case #3 of 3 presented at 2008 SAWC & WOCN
Non-healing diabetic foot ulcer WK #8 after initiation of MEDIHONEY®
Antibacterial Honey Wound and burn dressingsMedihoney® is the leading global brand of medical honey-based wound and burn care made from a speific honey, Leptospermum scoparium or Manuka honey, derived from a tea tree bush indigenous to New Zealand. Active Leptospermum Honey is the only species of honey shown in randomized controlled studies to help wounds - that have stalled under first-line treatment - to progress towards healing.
The most common usages of Medihoney® dressing are debridement of wounds and jump-starting the healing of stalled wounds including:
National Distributor of Medihoney®
� Arterial leg ulcers � Diabetic foot ulcers � Donor sites � Leg ulcers of mixed etiology � Oncologic wounds
� Pressure ulcers � Traumatic and surgical wounds � Venous stasis leg ulcers � 1st and 2nd degree burns
4 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 5
HEALTHLINES ISSUE #4
New research proves manuka honey really does help restore
bodily ills.
Researchers are racing against the clock to find a viable alternative to traditional antibiotics, as bacteria continues to build resistance against new drugs at a frightening rate.The field of chronic wound management illustrates the growing crisis. As antibiotic resistance becomes increasingly widespread, effective treatments for stubborn and slow-healing sores are becoming harder to find.Enter manuka honey, a natural product derived from the Leptospermum scoparium plant that has unique healing properties. New research from the ithree institute at the University of Technology, Sydney (UTS) shows manuka is the most effective type of honey for the treatment of these chronic wounds.UTS Professor Elizabeth Harry, who led the study in collaboration with Comvita, a New Zealand-based supplier of medicinal honey, says the research suggests nature may hold the answers to a range of ailments.The research team looked at two ingredients of honey known to inhibit bacterial growth: methylglyoxal (MGO), which is present at high concentrations in manuka honey, and hydrogen peroxide, which is present in many honeys at varying concentrations, including manuka.“Honey is naturally inhospitable to bacteria as it contains a complex mixture of antibiotic-like chemicals,”
Professor Harry says.“It’s an excellent example of how years of evolution in making honey can provide an effective, long-term medical solution,” she says. “Bacteria now have a finely honed ability to build resistance to traditional antibiotics, but are unable to do the same with honey.”The manuka honeys were the most effective at inhibiting growth of all four types of bacteria the researchers tested, she says. “Interestingly, the MGO level alone can’t explain the variation in the effects we saw,” she says. “The key to the effectiveness of honey is its chemical complexity – it contains several chemicals that inhibit bacterial growth, not just MGO.”However, the potential benefits of alternative therapies such as manuka honey continue to be ignored by many medical practitioners for a number of reasons, including a lack of funding for clinical trials of such therapies.“Many clinicians are wary of complementary treatments because of a lack of evidence supporting their use, and because it flies in the face of their clinical training,” says Dr David Johnson, director of Metro South and Ipswich Nephrology & Transplant Services (MINTS) and the medical director of Queensland Renal Transplant Service.“There’s a negative bias among a lot of clinicians. It’s probably because it’s outside of what they’re generally used to – it’s not within the usual conventional realm of medical thinking.”Dr Johnson uses Medihoney products to treat device-related infections – those linked to the use of medical equipment. He made the switch from traditional antibiotic treatments after conducting a trial to gauge the efficacy of Medihoney on his kidney dialysis patients’ catheter wounds. The trial showed the honey treatment was effective, affordable and well tolerated by the patients.“Most importantly, it wasn’t associated with promotion of
resistant bacterial strains,” he says.While Dr Johnson hasn’t embraced complementary medicines entirely, he says there are valid reasons for clinicians to remain open to the possibilities of natural products such as manuka honey, olive leaf extract, fish oil and Cordyceps sinensis, a fungus believed to protect the kidneys.“There are biologically plausible mechanisms for why they might be beneficial, so I think it’s worth exploring those things,” he says. “What I’d like to see is more trials being done in the area to confirm their safety and efficacy.”Professor Harry agrees, saying natural therapies have a lot to offer but have needed better science behind them to get clinicians on board.“It’s time to be open to alternative treatments that have had the stamp of approval by official regulatory bodies,” she says.Meanwhile, time to find an alternative for traditional antibiotics is rapidly running out.“Antibiotic resistance is a bit like climate change – we can turn our eyes away from it, but at the end of the day it’s there,” Professor Harry says.“What we need to do is decide to take action, and decide to be more open-minded about what’s possible.”This story written and produced by the University of Technology, Sydney, for The Sydney Morning Herald. Author Claire Thompson.
Research Articles: The Effect of New Zealand Kanuka, Manuka and Clover Honeys on Bacterial Growth Dynamics and Cellular Morphology Varies According to the Species Lu J, Carter DA, Turnbull L, Rosendale D, Hedderley D, et al. (2013) The Effect of New Zealand Kanuka, Manuka and Clover Honeys on Bacterial Growth Dynamics and Cellular Morphology Varies According to the Species. PLoS ONE 8(2): e55898. doi:10.1371/journal.pone.0055898 Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA) Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, et al. (2013) Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA). PLoS ONE 8(2): e57679. doi:10.1371/journal.pone.0057679
Buzz builds for honey treatmentsClaire Thompson UTS news room , Sydney Morning Herald – 21st March 2013
Finding Success with Active Leptospermum HoneyAaron Wodash RN, WCCAugustana Care Center, Minneapolis, Minnesota
Case Study
The goal of achieving wound closure is often challenging with complicated patients suffering with multiple co-morbidities. Even when choosing advanced wound care dressings and therapies often times thousands of dollars are spent without progress.This series describes patients suffering with wounds that were stalled in their progression toward healing despite receiving negative pressure wound therapy (NPWT).NPWT was initially chosen because of the large size wounds and significant amounts of exudate. However, they were still not showing improvement.
A change in the plan of care was necessary and it was decided to try Active Leptospermum Honey (ALH)* dressings for their known mechanism to jump-start the wound healing process. ALH dressings are known to have a low pH important to alter the environment of the wound bed and believed to be one of the mechanisms responsible for faster wound healing1. ALH has also been shown to have significant debridement properties2 and in our facility has often been used in lieu of more costly enzymatic debriding agents.The patients in this series had many challenging issues and medical complications including malnourishment, contractures, and the inability to communicate. Patient #1 presented with three stage IV pressure ulcers being treated with NPWT in combination with an enzymatic debriding agent 3x/week for a period of three months but was not showing expected progress. ALH Gel was first initiated in combination with NPWT and the remaining area of slough in the wound was quickly debrided after one week and the wound then began to reduce in size. The NPWT was able to be discontinued and ALH was continued in combination with a Super Absorbent dressing** being changed twice weekly. The rapid progress after months of little progress was considered remarkable.Patient #2 presented with a full thickness surgical wound also not demonstrating improvement with NPWT. It was decided to discontinue the NPWT and trial ALH after seeing the rapid response in patient #1. This wound also rapidly began to reduce in size and showed significant improvement with the use of ALH.
ALH has shown to be a cost-effective alternative to other costly wound treatment techniques. This data demonstrates situations of wounds not benefiting from NPWT but showing benefits within one week after the introduction of ALH. ALH is now considered at our facility earlier in the wound healing process rather than waiting until after other methods have failed or waiting until the wound has stalled.
Introduction
Methods
Conclusion
Patient 1
A 79 yo female patient was living at home with family receiving home health nursing services and she developed multiple stage IV pressure ulcers. Home health service stopped seeing patient because she required more care than they could provide. Pt was hospitalized for wound infection, UTI, bacteremia, dehydration, and severe protein-calorie malnutrition. Patient underwent incision and drainage with NPWT placement at the hospital and was admitted to our facility for LTC. Past medical history includes
Date Length Width Depth Area (cm2)
Volume (cm2)
% Area Reduction
% Volume Reduction
2/29/12 4.0 2.0 4.0 6.28 25.13Initial
MeasurementInitial
Measurement
3/7/12 2.9 2.5 3.2 5.69 18.22 9.4% 27.5%
3/14/12 2.7 1.8 3.2 3.82 12.21 39.3% 51.4%
3/21/12 2.6 1.9 2.1 3.88 8.15 38.3% 67.6%
3/28/12 1.8 1.3 1.8 1.84 3.31 70.8% 86.8%
4/3/12 1.5 2.0 1.8 2.36 4.24 62.5% 83.1%
4/11/12 1.2 1.3 1.0 1.23 1.23 80.5% 95.1%
Patient 2
Patient was an 81 year old female with multiple medical problems including: CVA, HTN, CAD, DM, hyperlipidemia, and fall with displaced R femoral neck fracture, s/pR hip hemiarthroplasty on 9/15/11. Pt was hospitalized for post surgical infection requiring explantation on 10/10/11 and then underwent incision and drainage with NPWT placement on 10/27/11. NPWT continued until 2/29/12 when the medical team changed the plan of care.to a plain calcium alginate dressing and foam cover, due to the wound being stalled. Biofilm was suspected in this chronic wound and little progress was seen with the plain calcium alginate. On 3/4/12 ALH Calcium Alginate dressing was started with a Super Absorbent dressing as a secondary dressing and the wound again began to progress. On 3/19/12, an NP changed the plan of care to wet to dry dressings daily. Again the wound failed to progress and ALH was reinstated on 4/7/12 via an order from ortho. The wound continued to improve with this plan of care.
Left IT
2/14/12 5/23/12
References
1. Gethin G, Cowman S. (2008) The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J. ; 5:185-194.
2. Gethin G. (2007) Leptospermum scoparium Honey vs. Hydrogel to deslough venous ulcers: A randomised controlled trial. EWMA
*MEDIHONEY® Active Leptospermum Honey Dressing, Derma Sciences, Inc., Princeton, New Jersey. *XTRASORB® Super Absorbent Dressing, Derma Sciences, Inc., Princeton, New Jersey.
After Failures with Negative Pressure WoundsAaron Wodash RN, WCCAugustana Care Center, Minneapolis, Minnesota
CVA x2, DM II, anemia, hyperlipidemia, HTN, and severe bilateral hip and knee contractures. Patient was bedfast, non-verbal, and immobile.
On 2/29/12, patient presented with stage IV left ischial tuberosity (Left IT), Right ischial tuberosity (Right IT) and Left Trochanter ulcers, which were stalled. The Left IT ulcer had been treated previously with collaginase and NPWT 3x per week x 3 months. For a short period of time ALH Gel was trialed under NPWT and after
improvement NPWT was discontinued and the plan was changed to ALH Calcium Alginate with Super Absorbent dressing 2x per week. A slough plug covering 5% of wound bed debrided after one week of ALH treatments being used. ALH started 3/7/12 and was utilized until complete wound closure. The Right IT and Left Trochanter wounds also began to show marked improvement with the change in the plan of care to ALH.
Please note that the increase in depth measurements were due to a change in measurement technique and documenting a more lateral depth/tunnel. There was not an increase in true depth but in fact was an attempt to more accurately capture the wound volume by measuring the tunnel at 10:00 to the deepest point.
2/14/12 5/23/12
8 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
OptiSonic™ features and benefits: � The viscous transparent gel has
been specifically developed to be acoustically correct for the broad range of ultrasound frequencies currently in use.
� The OptiSonic™ range is made from a hypoallergenic non-sticky formulation to ensure maximum patient comfort.
� The products will not stain skin, clothing or transducers.
� OptiSonic™ is available in 250ml non sterile bottles and 20ml sterile sachets.
� The 250ml bottles have an easy-open cap and allow larger amounts of gel to be dispensed on the human body.
� The individual 20ml sterile sachets are for use on a single patient and for ultrasound treatments where gel sterility is required.
OptiSonic™ is a range of ultrasound gel for use on all types of diagnostic and therapeutic ultrasound scan machines as well as cavitation and weight loss equipment.
OptiPro™, class IIa medical device Wipe, is a 70% alcohol cleansing wipe for use on skin prior to injection.Supplied in individual sa-chets and available in boxes of 100.
A class IIa medical device cleansing wipe containing 70% alcohol and 0.5% chlorhexidine. Widely used in Government funded hospitals in the UK. Supplied in individual sachets and available in boxes of 100.
A class IIa medical device disinfectant wipe containing 70% alcohol and 0.5% chlorhexidine. Widely used in Government funded hospitals in the UK. Supplied in individual sachets and available in boxes of 100.
1102 Pre-Injection - 70% Isopropyl Alcohol Wipe 60mm x 30mm OptiPro™ Pack of 100 Case of 10000
PRE-INJECTION ALCOHOL WIPES
OptiPro™, class IIa medical device Wipe, is a 70% alcohol disinfectant wipe for use on skin prior to injection.Supplied in individual sachets and available in boxes of 100.
A class IIa medical device disinfectant wipe containing 70% alcohol and 0.5% chlorhexidine. Widely used in Government funded hospitals in the UK. Supplied in individual sachets and available in boxes of 100.
1102 Pre-Injection - 70% Isopropyl Alcohol Wipe 60mm x 30mm OptiPro™ Pack of 100 Case of 10000
PRE-INJECTION ALCOHOL WIPES
OptiPro™, class IIa medical device Wipe, is a 70% alcohol disinfectant wipe for use on skin prior to injection.Supplied in individual sachets and available in boxes of 100.
MEDICAL DEVICE
8 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 9
HEALTHLINES ISSUE #4
NEWCross ValveTechnology™
Cross Valve TechnologyTM
9 Easy to breath through chamber 9 Single patient use 9 Portable size 9 Easy to dismantle and clean 9 As used in Australian hospitals 9 1 year warranty
Space Chamber Plus® is a registered trademark of: Medical Developments International Limited ABN 14 106 340 667 7/56 Smith Road Springvale Victoria 3171 Australia Telephone +61 3 9547 1888 Fax +61 3 9547 0262 Email: [email protected]
Web: www.medicaldev.com
For general sales & enquiries contact EBOS Customer ServiceFREE CALL: 1800 269 534 | FREE FAX: 1800 810 257
Cross Valve TechnologyTM
Ensures very low resistance when inhaling your medication (breathing in) and also allows you to easily breath out through the chamber
Transparent Polycarbonate Chamber
Allows clear view of the valves and their movement which provides confirmation of correct inhaler operation and usage.
Multi-purpose mouthpiece
Use directly as mouthpiece, is compatible with standard 22mm face mask. Can also be attached to tracheotomy or endotracheal tube.
Universal Inhaler Base Compatible with most types of aerosol medication (Puffer)
10 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
AirPal PVR (Premium Value Reusable) Platform Air Assisted Lateral Patient Transfer SystemAirPal invented Lateral Air Transfer and Positioning Technology and has been the leader in this field for 30 years.
The Airpal is designed specifically to reduce the risks associated with transferring patients from bed to stretcher and other areas of the hospital. AirPal dramatically reduces back injuries and increases the efficiency of hospital staff as fewer are required to position or transfer patients, all the while improving the patients safety and comfort.
The AirPal Platform leads the market with its patented features, quality of design and value – and is unique among the competitive products available today.
What distinguishes the AirPal Platform from competitive products are the many innovative design features and the high level of attention used in sourcing materials. The AirPal platform also offers the widest range of width sizes and the broadest line of Transfer Pad types for special healthcare applications.
� Only transfer pad on the market with Five Year Warranty
� Available in multiple sizes � AirPal air supply available, and
compatible with most equivalent air supply systems
� Compliant with legislative guidelines for safe patient handling
Benefits
� Dramatic reduction in staff injuries related to lateral patient transfers and positioning
� Requires less staff for transfers than traditional drawsheet or transfer board
� Increased patient comfort & reduced patient anxiety with transfers
� Strong durable design provides for exceptional service life of over five years (Five Year warranty)
� Capacity up to 1,200 lbs (500 kgs)
Features
� Reduces sustained and peak forces required for lateral patient transfer and positioning
� Patented extended ergonomic handles protect caregivers from injury
� Patented extended length sani-liners available - both durable & disposable
� Exclusive stabilization bands provide enhanced patient stability even if off-centered
� Snaps are made of nickel (not an issue for MRI)
� Use of Velcro eliminated everywhere
Available in AIRPAL N SERIES and AIRPAL L SERIES
N Series – the patient transfer pad is constructed of a launderable nylon twill fabric treated with a bacteria coating, added to waterproof, vapor-permeable urethane inner coating, and a static check coating to prevent the buildup of static electricity
L Series – the L series transfer pads are the same as the N Series, except the nylon top surface is replaced with Lectrolite, the same conductive material used to cover operating room table pads and stretcher pads. Application uses are in areas where excess fluids could be encountered (ER, Trauma, OR, Cardiac Cath Lab and Obstetrics)
Extended Handles: allow use siderails during transfer and help to maintain posture by extending the caregivers reach.
Stabilization Bands: help to center patients who are slightly off-center during inflation and allow greater control during transfer
Protective Liners: extend over sidewalls to provide extra protection from soiling and fluids. The unique snap system secures the liner in place so it does not move or bunch up when positioning the patient on the transfer pad. Disposable versions of the liners also have the same features
Medical Fabrics: AirPal utilizes highly regarded healthcare fabrics (Herculite Sure-Check Fusion III, Lectrolite). The patient surfaces are double layered so that seams are covered and patients are further protected from shear.
Internal Radial Stabilization Bands (Distribute stresses and helps to re-centre
patient upon initial inflation)
Dual Patient Safety Straps
Integral Handle Attachment Points (Sewn into sidewall seams and stabilization bands to
produce an extremely strong and durable product)
Extended Length Color-Coded Handles
10 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 11
HEALTHLINES ISSUE #4
The AirPal stand is constructed of stainless steel and utilizes and IV footprint for mobility and stability
Single-Patient-Stay disposable Transfer Pad (SPS)One Patient – One PadThe AirPal ‘Single Patient Stay’ is a premium quality disposable transfer pad devised to last for the duration of the patient hospital stay, designed with advanced fabrics and coatings to hold up for multiple lateral transfers.
The AirPal SPS is easy to wipe clean with standard anti-bacterial cleaners – and under certain conditions it can even be laundered. The AirPal SPS offers exceptional cost-effectiveness and economy, just what you would expect from the healthcare specialists at AirPal and EBOS Healthcare.
� Lower cost per patient than most single-use disposables*
� Available in multiple sizes
� AirPal air supply or compatible with existing air supply systems
Single Patient System Benefits for Staff
� Dramatically reduces staff injuries and worker’s compensation costs
� Improved morale and efficiency
� Eliminate reprocessing (laundering)
Single Patient System Benefits for Patients
� Increased patient comfort and safety during transfers
� Reduces skin bruising
� Enhanced infection control (reduces the risk of cross contamination)
* Based on acute care application. AirPal data.
Features
� Available in 3 sizes to accommodate most patient sizes
34” wide x 78” long 39” wide x 78” long 50” wide x 78” long
� Safe working load of 1000 lbs (453 kg)
� One patient – one pad � May be used for multiple
transfers during patient hospital stay*
� Made with anti-microbial anti-stain coated advanced fabrics that are easy to wipe clean
� AirPal Air Supply available; also compatible with existing air supply systems
� Compliant with legislative guidelines for safe patient handling
EBOS Healthcare is distributor of AirPal Platform and SPS transfer pads in
Australia
For more information or a trial of the new AirPal, please email [email protected] or contact EBOS Customer Service on 1800 269 534
CASE STUDY www.airpal.com Air-assisted Pa
tient
Tra
nsfe
r Sys
tem
s Patient Transfer Systems, inventor of the Lateral Air Transfer Technology, has been a leading innovator in patient transfer for over 20 years. Patents for the Airpal® have been granted in 13 European countries
The Airpal is designed to reduce the risks associated with patient handling during transfer of patients
from bed to stretcher to other areas of the hospital. The Airpal works by the release of low pressure air through perforated chambers.
The nylon mattress is placed under the patient and inflated using a lightweight, portable air supply. The patient is transferred on a cushioned film of air, allowing just two members of staff to perform a task which previously may have required four to eight, with minimal risk of injury to both staff and patient.
Advantages include fewer musculoskeletal injuries among staff, and an associated reduction in compensation claims, lost work days and direct medical expenses, as well as increased efficiency with fewer staff required to transfer patients.
Integris Health is Oklahoma’s largest not-for-profit healthcare system and second largest employer, with 10 hospitals, rehabilitation centres, physician clinics, mental health facilities, independent living centres and home health agencies throughout the state. Integris Health has approximately 8,000 fulltime employees.
In February of 2003, the company won the Oklahoma Department of Labor Award of Excellence, and in 2004 the Oklahoma Safety Council’s Award of Excellence as well as the first CREST Award from the Department of Labor for its safety programmes, and safety
policies, as well as its Disability Management Program, which have provided a safe work
environment for its employees and reduced worker’s compensation costs by more than 50% over a three year period.
These innovative programmes have saved Integris Health $15 million over the past five years. Integris has been able to cut its workers’ compensation budget by more than 50% over a six-year period, while payroll, number of full-time employees and productive hours has continued to increase each year.
In 1997 Integris Health’s workers’ compensation budget was $4.8 dollars for workers’ compensation costs alone. By the year 2000, Integris Health had reduced its workers’ compensation budget to $2.5 million per year. Not only are workers’ compensation costs paid out of this budget, but also the salary for three RN case managers and costs of all ergonomic equipment.
In 1997 Integris Health’s key cost driver was back injuries to nurses from lifting and transferring patients. Integris began to look at ways prevent these types of injuries. One component of the Disability Management Program is the Safe patient handling policy, which prevents manual lifting and lateral transfers of patients Airpals are provided to each patient care unit, as well as to central transportation.
Per policy, no patient is to be transported without the use of the Airpal and no lateral transfers of patients are to be made without the use of an Airpal. During product selection, several types of lateral transfer devices were evaluated. Integris Health chose the Airpal for its high degree of patient comfort, ease of use and cleaning, and reduction of injury to employees.
The Airpal allows one employee to move an incredible amount of weight
with no risk of injury to the patient or themselves. Different types of procedures can be performed while the patient remains on the Airpal from X-rays
to surgery. Integris Health’s labour and delivery unit performs all caesarean sections on the Airpal. Use of the Airpal has played an integral part in helping
Integris Health reduce its work-related injuries and maintain retention of staff.
Resources: www.airpal.com
Case study: Transfer of the patient with morbid obesity – a problem now made easy
patient transfer:
Michael G Sarr MD, Michael Kendrick MD, Jane Mai RNDepartment of Surgery, Mayo Clinic, Rochester, Minnesota, USAObesity has become a national health and economic crisis in the United States and many countries in Europe. Even more frightening are the statistics showing the ever-increasing prevalence of obesity in the last decade.
The implications to the healthcare system are immense. In addition to the direct weight-related medical morbidities of obesity, hospitals face other more mundane, yet practical, problems — how to care for, transport, and move the patient with severe obesity. Beds, chairs, wheelchairs, stretchers, bathroom commodes, etc, need special safeguards to be able to bear weights of >130 kg (even as great as 400).
The transport of such patients to and from tests are, of course, facilitated by patient cooperation in getting on/off the stretcher, etc. But how about transfer of the severely obese patient unable to help, such as the patient immediately postoperatively in the operating theatre or the severely ill patient in the Intensive Care Unit or in the Emergency Department? The protection the healthcare deliverer in the workplace as well as the patient has become of paramount importance.
Our first experience with this ostensibly “simple” problem of patient
transfer from the operating theatre table to the heavy duty stretcher became evident when planning a bariatric procedure on a patient weighing 350kg.1 Because of concerns of potential injury to patient and operating theatre personnel, we “recovered” the patient in the operating theatre until he was awake enough to aid his own transfer from table to stretcher and then to his bed. Similar concerns related to the cognisance of back injuries of nursing and paramedical personnel throughout the hospital lead to a review of aids of patient transport/transfer.
The Airpal Patient Lateral Transfer Device (manufactured by Patient Transfer Systems, Inc, Center Valley, PA., USA) offers a safe and minimal assistance device that markedly facilitates transfer of the supine obese patient from bed to stretcher, etc. The Airpal lift system is a smooth air-type mattress placed on the bed or stretcher prior to the patient lying down that slides easily when inflated.
This deflated, flat “mattress” is then inflated rapidly (~20 seconds) by a detachable electrical air pump just prior to lateral patient transfer; the patient then slid virtually effortlessly to the receiving surface (usually requiring one to three people for “stabilisation”), then rapidly deflated. The deflated mattress then travels with the patient to aid future transfers.
This Airpal system was adopted rapidly also in our intensive care unit
and patient nursing ward. No longer are 6-10 people in the operating theatre necessary to transfer the anaesthetised patient from bed-to-stretcher or from stretcher-to-bed on the ward, and the risk of injury is reduced.
Concerns about safety in the workplace (both for the staff as well as the patient) have stimulated an intense interest in various modes of patient mobilisation. We are currently evaluating several types of ceiling-mounted and portable patient “lifts” to aid all types of patient mobilisation such as lyingto-sitting, sitting-to-standing, and support while walking, in addition to lateral-to-lateral transfer. With the increasing prevalence of severe obesity, hospitals face growing concerns of both patient and personnel safety in the transfer and care of these patients.
A continued focus on this problem is imperative with the ultimate goal being to provide aids to patient mobilisation such that patient care personnel need not be concerned about such related work-place injury, and patient safety is maximised.
Reference1. Sarr, MG, Felty CL, Hilmer DM, Urban DL, O’Connor G, Hall BA, Rooke TW, Jensen MD. Technical and practical considerations involved in operations in patients weighing more than 270 kg. Arch Surg 1995;130:102-5.
14 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Eschmann is proud to have been awarded accreditation from Safecontractor for its commitment to achieving excellence in health and safety.
Safecontractor is a leading third party accreditation scheme which recognises very high standards in health and safety management amongst UK contractors. Working in the healthcare sector, specialising in the manufacture and installation of market leading decontamination and operating theatre
equipment, Eschmann take the responsibility of the health and safety of their employees and those they work with onsite very seriously.
Safecontractor is applicable to most sectors although it is particularly relevant to food manufacture, property, facilities management, retail and leisure sectors, all of which are big users of contracted services. Under the safecontractor scheme, businesses undergo a vetting process which examines health and safety procedures and their track record for safe practice.
John Kinge, technical director of safecontractor said, “Major organisations simply cannot afford to run the risk of employing contractors who are not able to prove that they have sound health and safety policies in place.” “More companies need to understand the importance of adopting good risk management in the way that Eschmann has done. The firm’s high standard has set an example which hopefully will be followed by other companies within the sector”.
Top Safety Accreditation for Eschmann
Eschmann is pleased to introduce a new articulating arm board with ball joint release for easy articulation.
The popular “one hand ball joint release” design permits multi-directional movement and is designed to meet the exacting demands of patient positioning needs. Directional movement is ideal for prone and beach chair positioning and supports patient’s arm during procedures and administering of IVs.
The Swedish manufactured arm board is available complete with pressure reducing
mattress and integral clamp to suit UK rails. Simple to use and articulate by squeezing lever, positioning armboard and releasing lever.
For more information on the new articulating arm board, please call Kylie Upton, Eschmann Product Manager on 0412 203 957 or email [email protected]
Eschmann Innovation – New Articulating Arm Board
14 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 15
HEALTHLINES ISSUE #4
From Pam Barratt, Director of Nursing, Mackay Specialist Day Hospital (QLD)
When the Mackay Specialist Day Hospital opened in 2001 we inherited a second hand manual Eschmann operating table. The table performed reliably and faithfully and was suitable for our surgical specialties but with an increased case load we eventually budgeted for a fully electric table with a higher safe working load than what the Trans X offered.
A sister facility within the Virtus Health Group had converted to a standardised fleet of Eschmann T50 operating tables for lithotomy positioning from EBOS Healthcare and recommended we
consider it for Mackay Specialist Day Hospital.
Having worked with all models of the Eschmann tables throughout my nursing career I felt comfortable adopting the newest, latest model in line with our sister facility and trusted the T50 would suit our clinical needs and user’s preferences.
The staff have reported they are happier with the brand new electric T50’s ease of use, wider table top, lighter lithotomy end and higher safe working load. The Trans X is still in occasional use and we anticipate with continued routine annual preventative maintenance it will continue to be reliable.
Rave Review For The Eschmann T50
Happy team at Mackay Specialist Day Hospital. left to right: Andrew Yerramsetti, Pam Watson, Dot Windsor and Nita Lieschke
Eschmann T50 Gynae and Obstetrics Operating Table � Developed specifically for
Gynaecology and Obstetric procedures
� Shorter table top reduces manual handling
� Powered back rest allows for ‘assisted delivery’ in a single movement
� The cut out in the table base allows improved surgical access and if required the positioning of a ‘kick bowl’
Benefits � Full bariatric capable table with
450kgs maximum patient weight and extendable 600mm wide table top to suit all body types
� Maximum patient weight 300kg supine in lithotomy and extendable 600mm wide table top to suit all body types
� 100% electric powered with in built independent override – newer, safer and more environmentally friendly technology
� Interchangeable head and leg sections with ‘auto lock’ feature offer optimal and easy patient positioning
� Seamless molded mattress – Antistatic, no Velcro and Latex Free. Open cell visco elastic foam offering unparalleled pressure relieving qualities. This along with the seamless ABS covered tabletop provides the ultimate ‘easy clean’ infection control solution
� 100% x-ray translucent table top with inbuilt, unrestricted x-ray Cassette tunnel running the length of the table. The offset table top and slim-line column offers unrestricted C-Arm acces
16 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Vernacare introduces New Vernatray in AustraliaVernacare launches new anaesthetic medication safety tray which replace plastic and stainless steel trays. Medical Product manufacturer Vernacare UK has just launched a new single-use anaesthetic medication safety tray – designed by theatre staff for theatre staff to reduce the risk of operating theatre error. The Vernatray is a single-use disposable pulp tray with individual channels to ensure the correct alignment of syringes and a separate storage area for ampoules and sharps.
This disposable tray is intended to replace plastic and stainless steel trays where the medication is stored in one single compartment – making it difficult to locate the relevant syringe and hence increasing the risk of mistakes.According to the UK Association for Perioperative Practice, the majority of critical incidents in anaesthesia arise from human error, with 128,000 reported patient safety incidents from surgical specialties from October 2006 to September 2007.
Said Jane Kent, New Product Development Manager for Vernacare UK: “The Vernatray makes it easier for theatre staff to locate the relevant equipment and reduces the risk of incorrect medication being administered. In addition, the single-use pulp avoids infection risks associated with re-using plastic and stainless steel receptacles and saves cleaning time as the biodegradable pulp can be simply disposed of in clinical waste or via maceration.“The Vernatray was created in partnership with the UK NHS Innovations South West and has been designed by theatre staff for theatre staff. The original idea and thinking came from anaesthetists who identified the need to increase safety by organising medication better. We have taken their concepts to a new level and created a single-use tray that meets the safety needs of modern healthcare practice.”The patented tray has been designed and tested by Vernacare with detailed input from front-line clinicians. Theatre staff from four UK NHS Trusts helped to
evaluate an initial prototype. The design was then modified to reflect their views, and a second prototype tray created in single-use pulp. Evaluation of the Vernatray has been carried out at four UK hospitals, with 99% of clinicians reporting that they found it easier to correctly identify labels on syringes and 100% of respondents stating that the syringes were stable in the tray.EBOS Healthcare, who have exclusive distribution of the Vernacare system of disposable pulp products and macerators for Australia, will be introducing the new Vernatray in Australia in mid July.
For more information or to register for free samples or a trial of the new Vernatray, please email [email protected] or contact EBOS Customer Service on 1800 269 534
Conference NewsEBOS Healthcare will attend the following conferences, exhibiting AirPal, Heine, Eschmann and Verncare. Be sure to come and visit, you might take away some great clinical solutions and ideas!
Westmead Hospital Week NSW 7-9 August 2013
Acorn AGM & VPNG Conference Victoria 8-9 August 2013
ACIPC 2013 Gold Coast QLD 30 September-2 October 2013
AHSPO Annual Conference VIC 23-25 October 2013
SAPNA Conference SA 18-19 October 2013
ORNA WA WA 25 October 2013
NSW OTA 2014 Conference NSW 6-8 March 2014
ACORN National Conference Victoria 20-24 May 2014
16 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 17
For more information or to register for free samples or a trial:
The VernatraySingle-use pulp medication safety tray
• Four individual channels for placing syringes – reduces the risk of incorrect medication being administered
• Single Use – a clean tray every time reduces the risk of cross infection and eliminates nurse cleaning
• Maceratable and biodegradable – can be easily disposed of in the macerator or clinical waste
NEW
18 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
HEINE Optotechnik is a developer, manufacturer and the world’s largest exporter of hand-held, primary diagnostic instruments. Founded over 65 years ago in Germany, HEINE has been setting the standard for high quality medical diagnostic instruments in terms of Durability, Performance, Function, and Safety for over six decades.
Our philosophy is to provide the absolute best diagnostic images to give the best patient outcomes. And it is a point on which we will not make any compromises.
To ensure we remain at the trend setting edge of technology as it is evolving at ever increasing speeds, we invest heavily in research and development. Our latest project for our R&D engineers was to create a superior medical LED lighting system focusing on 5 key elements, the result was the creation of LED HQ - LED now in HEINE Quality!
During this development of LED Instruments we have successfully solved many of the challenges associated with LED illumination, which range from integrating the technical and optical characteristics of LEDs into our small instruments, to dealing with the huge tolerances in the illumination characteristics created in the manufacturing process. The results are instruments that meet our exacting Quality Standards for HEINE, providing stunningly bright, homogenous light, optimal colour temperature, exceptional colour rendering index performance, with precise brightness control over the entire range of illumination where needed.
Reds stay red. Blues stay blue. For an absolutely reliable and accurate diagnosis.
LED in HEINE Quality – 5 advantages that set a new standard in LED Illumination:
HEINE launches a new series of LED diagnostic instruments and defines a new standard for premium LED-Technology – in HEINE Quality.
HOMEGENEITY: Homogeneous light spotedge-to-edge. The field of view is uniformly illuminated edge-to-edge.
COLOUR RENDERING:Reliable and accurate diagnosis.
LIGHT INTENSITY:Optimum brightness for the examination.
LONG-LIFE:50,000 Hours working life.
THERMAL MANAGEMENT:Consistent quality and performance.
COLOUR RENDERING
18 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 19
HEALTHLINES ISSUE #4
HEINE Binocular Loupesand Loupelightsas seen at the Plastic Surgery Congress and Royal Australasian College of Surgeons Conference 2013.
HIGH MAGNIFICATION AND SHARP, CRISP IMAGESAs with all HEINE products, we are committed to manufacturing the best quality instruments on the market - our binocular loupes are no exception to this.
We integrate state of the art optics, high-tech materials and innovative features to create a comfortable, precise and modular magnification/illumination system to suit every practioners needs.
Binocular LoupesFor magnification
� Achromatic � State of the art optics � Edge to edge clarity � Large view and depth of field
COMFORTABLE
PRECISION OPTICS
IMPROVES POSTURE
SHADOW FREE LIGHT
LoupelightFor illumination
� Homogenous � Defined light spot � Compact and Lightweight � 17 hours working time
YEAR
SGU
ARAN
TEE
MOUNTING OPTIONS:
HEADBAND
S-FRAME
Binocular Loupes and LoupelightMagnification and Illumination
20 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
HEINE F.O. LED Laryngoscope Range
YEAR
SGU
ARAN
TEE
Heine laryngoscopes have distinguished themselves with their premium finishes, excellent light transmission and overall quality.
Our comprehensive blade and handle range has now been updated with our latest technology – LED in HEINE Quality, which means our laryngoscopes are now further ahead of conventional F.O. blades and handles than ever.
View our range at the 34th ANNUAL COMBINED ANZCA/ASA CME MEETING on 27th July 2013.
For exclusive special pricing or exclusive offers, please contact your EBOS Key Account Manager.
� Guaranteed light output for 5 years � Guaranteed for 4000 autoclave cycles � Easy Intubation � HiLite fibre optic bundle for superior light transmission
BladesREUSABLE & DISPOSABLE
BLADE SIZES 00 TO 5
SUPERIOR LIGHT OUTPUT
ISO 7376 COMPLIANT
HANDLES
REUSABLE BLADES
5 YEAR WARRANTY ON:
� Handle shell conveniently separates from battery insert for easy cleaning � Up to 5 hours working time � Available in Slim, Short, Angled and Standard
Handles
BATTERY INDICATOR
2.5V BATTERY POWER
3.5V RECHARGEABLE
SMART CHARGE SYSTEM
LED AND XHL TECHNOLOGY
ANGLED HANDLE (KESSEL)
20 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 21
HEALTHLINES ISSUE #4
Hand Hygiene Compliance: It’s Time For A ChangeFor over 70 years, the Deb Group has been providing skin care solutions in the form of hand hygiene products and dispensers, for all types of workplace and public environments, spanning industrial, commercial, automotive, food and healthcare sectors. Deb’s skin care solution for the healthcare sector has been specifically designed to satisfy all occupational, community and acute healthcare needs; comprising a complementary range of skin care products & support activities to help raise the level of staff compliance, improve skin condition and reduce the risk of cross-infection.Deb has gained a deep insight into the factors that affect skin care compliance by working with healthcare professionals, to increase levels of hand hygiene, for over 20 years. As such, Deb also offers advice on how to drive improvements and encourage behavioural change amongst colleagues, patients and visitors to prevent the spread of harmful bacteria and viruses.
Maintaining good skin condition is vital to protecting the health of both staff and patients. The Cutan hand hygiene product range encourages best practice to achieve safe and acceptable levels of care through the use of a Hand Hygiene Procedure, which consists of 3 simple stages to achieve maximum hand hygiene compliance: Cleanse, Sanitise and Restore.Deb also offers a bespoke service where dispensers can be tailored to meet specific requirements, providing choice of colour, logo and message. Customised dispensers are a great way to raise awareness of the hand hygiene facilities available and also to promote an appropriate infection prevention message whilst reflecting the organisation’s corporate style.There has never been a better time to talk to your EBOS Key Account Manager about improving your hand hygiene provision with the Cutan range.
Cleanse – Apart from cleaning any visible soilings from hands, the physical action of a good hand washing technique will remove high levels of bacteria and viruses present on the skin.
Sanitise – Hand sanitising is an effective way to reduce bacterial counts on visibly clean hands, when access to soap and running water is inconvenient.
Restore – This is the most important step in maintaining good skin condition. As a consequence of frequent hand washing, it is necessary to regularly replenish the natural oils and secretions lost from the skin via the use of a conditioning cream.
22 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
For more information:
Join the Evolution
Break the cycle of cross-infection with Vernacare’s new 100% disposable solution for patient toileting ...Vernacare’s new bedpan and disposable pulp support not only helps to reduce the risk of cross infection, but also supports hospitals’ sustainability agendas, providing environmental, financial and nursing time savings.
The products have been developed collaboratively with clinicians across the globe, to provide a 100% disposable solution to patient toileting.
The fully disposable system reduces the risk of cross-infection associated with re-usable plastic products and helps tackle spiralling HAIs costs.
� Intuitive tear-shaped design minimises contact with patient’s skin
� Curved edges allows easier patient positioning
� Ergonomic design reduces pressure on coccyx
� Can be used in all major commode chair brands
� Independent support pillars distribute weight evenly
� Inner ribbed wall provides strength when used in bed
� Can be disposed of in pulp disposal unit
Financial Benefits
� Reduced HCAI costs
� Rationalise multiple products
� Reduced cleaning costs
Environmental Benefits
� Eliminate plastic supports being landfilled
� Reduced energy consumption vs washer disinfectors
22 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Vernacare Launch New Disposable Bedpan & SupportAs a leading provider of infection prevention products and solutions, Medical Product manufacturer Vernacare UK are changing how patients are toileted in hospital and aged care environment with the launch of their fully disposable pulp Bedpan and Support.
The innovative system, which makes use of a new disposable pulp bedpan liner and disposable pulp support, is a significant step forward for infection prevention.
The design of current pulp bedpans has not evolved for decades, and has always required the use of a plastic support when used to toilet patients in bed. Vernacare have addressed this challenge through an extensive project to develop the world’s first fully disposable support, helping to minimise the risk of cross infection.
This challenge has resulted in extensive detailed design work and global field-based evaluations, gaining very positive support from clinicians and patients alike.
“The new product combines increased user comfort with functional performance -and we believe that the removal of a plastic support and the switch to Vernacare’s unique fully-disposable system will continue to help in driving down infection rates and support patient safety” said Emma Sheldon, Vernacare Global Marketing Director.
The new system has been developed with patients in mind, as the unique patented design will help improve the patient experience, by providing a more comfortable and dignified alternative to traditional bedpans.
“The design has been developed collaboratively with customers from across the world, ensuring it addressed the needs of the global healthcare market in terms of functionality and ease of use for both patient and nurse.” added Jane Kent, Vernacare New Product Development Manager. “The disposable nature of the support will provide significant cost savings to facilities by helping to reduce their infection rates, and we have seen similar interventions produce exceptional results, such as the study involving the Vernacare Washbowl, conducted at Salford Royal Hospital for example”.
In February 2007, the Vernacare detergent proof Washbowl was introduced as a part of several interventions at Salford Royal NHS Foundation Trust. The study found that over a 6 month period, cases of Clostridium Difficile infection reduced by 56%*, and have been maintained since that time.
Vernacare’s award winning detergent proof washbowl was recently showcased at the Infection Prevention Society Conference & Exhibition on 1-3 October
2012, alongside the latest products in Vernacare’s new product development pipeline.
The new system of disposable bedpan and bedpan support will also reduce the environmental impact and cost of processing plastic supports and will provide a significant time saving for nurses, which will in turn release more time to spend caring for patients.
For further information, free samples or to arrange a free trial, please contact us at [email protected]
Reference.Reducing Clostridium Difficile infection in acute care by using an improvement collaborative - Power M, Wigglesworth N et al, Salford Royal NHS Foundation Trust, UK, BMJ 2010; 341: c3359
Bedpan & support
24 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Epworth HealthCare have been working closely with the EBOS Infection Prevention team for almost a decade, and currently use a wide range of the Infection Prevention products distributed by EBOS Healthcare across their facilities.
Early users of macerators and pulp products since 2004, the installation of 9 Macerators in the Epworth Eastern Campus was the start of this strong relationship. In 2012 the transition from tuffie detergent wipe to Tuffie 5 hospital-grade cleaning and disinfecting wipes was successfully completed, after a long extensive trial period.
Lauren Phillips, Infection Control Consultant at Epworth HealthCare, says: ‘The trial of Tuffie 5 was definitely successful. Epworth were already using Tuffie detergent wipes before Tuffie 5 became available, and we were eager to introduce Tuffie 5 throughout our facilities; the advantage of cleaning and disinfecting in a one step clean meets the Australian infection control guidelines, and because the range is so versatile it works well in all of our clinical areas.”
‘We followed the same trial process with the Cutan Foam Skin Sanitiser prior to introduction of the product. Staff chose this product over all others trialed. Simultaneously we implemented our hand hygiene program and the new alcohol based hand rub Cutan across all of our facilities. We are proud of the results achieved from this introduction, our hand hygiene compliance now sits well above the 70% Victorian benchmark for all clinical areas within Epworth HealthCare.’
Another small addition provided by DEB Australia was the customized dispensers.
Kerry Blewitt, Key Account Manager IP at EBOS says: “The Infection Prevention Division at EBOS Healthcare prides itself in supporting Epworth Health with extensive customer service. Our goal is to grow with Victoria’s largest non–for– profit private Health Care Group, and as leading provider of medical and surgical products in Australia we share Epworth’s commitment to further innovation and excellence in the Australian health system. We offer constant support and training in the many current redevelopments like Epworth Richmond, Hawthorn and Camberwell, where we make sure we are on hand to provide
assistance with the installation of Cutan Hand Sanitizer and Tuffie 5 wipes as soon as the redevelopments are complete”.
Kerry has just received a further order for macerator installation at the new Richmond building, a result of the Infection Control team acknowledging the infection prevention advantages of using single-use disposable items for waste management.
Working Closely With Epworth HealthCare
24 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 25
HEALTHLINES ISSUE #4
Full Supply Chain Solution for Hobart PrivateIt was a happy day for EBOS Healthcare and the Supply Chain Team at Hobart Private when back in June 2008 Hobart Private completed the transition from sanitizers to the V2020 Macerators in all wards and Day Surgery.
Hobart Private had little or no storage space available to store pulp supplies, so EBOS and the Hospital agreed on a full supply chain solution, where EBOS’ Hobart warehouse delivers directly to the wards on a weekly basis, without any supply going through their small warehouse.
Since 2011 Simon Burns, Key Account Manager for EBOS, runs his weekly visit at Hobart Private, checks that stock of consumables and pulp products in the hospital’s pan rooms is adequate based on the requirements list provided by the Hospital, and places their weekly order when stock is below expected levels.
This means that Hobart Private doesn’t have to worry about stock levels, doesn’t have to place orders and, most importantly, doesn’t have to use scarce warehouse space to store bulky pulp supplies. It is a smooth collaboration between the Hospital and EBOS Sales and Warehouse teams which shows how EBOS can help find a solution to any situation our Customers may be dealing with.
Hobart Private uses 10 x V2020 Macerators and a core range of Vernacare pulp products: urinals, bedpans, slipper pans, bowls and Vernagel.
Andrew MacFarlane from Hobart Private says: ’this has worked out perfectly for me; the service that EBOS provides every single week means that I don’t have to worry about pulp stock at all, it’s always there and we have not run out once. Simon and the EBOS Warehouse team do a fantastic job, I wouldn’t have it any other way’.
Tuffie5ADHalfPage123x202.indd 1 12/06/12 10:20 AM
26 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
Vortex Macerator. Advancing Infection prevention in hospitals and aged care facilities around the globe.The Vortex Macerator incorporates pioneering design features and has been manufactured for maximum efficiency by Vernacare, the global leaders in pulping technology.
The innovative hands free opening mechanism, LCD display and built in anti-bacterial deodorizer plus the unique twin bladed maceration process, mean the Vernacare Vortex is the preferred disposable pulp unit allowing fine maceration for free flowing drains.
The Vortex’ Twin blade action – unique to Vernacare it creates a vortex that pulverises the macerator contents and causes any foreign objects to get caught up in the blades rather than flushing to sewage. Content is macerated into fine watery slurry that will flow freely through drains
The main benefits of the Vernacare human waste disposal system – which include macerator and a full range of single-use, maceratable pulp containers are:
Greatly reduced risk of cross-infection. The Vortex disposes of four single-use bedpans or urine bottles every two minutes, with no waiting around to unload processed bedpans, no unhygienic stacking of soiled receptacles, and no cross contamination from inadequately cleaned bedpans.
Innovative new features ensure even greater levels of infection control: Hands-Free Opening, Cleaner Macerator Drum, Hygienic lid seal – no aerosolleakage, Blockage Prevention, Anti-Bacterial Deodoriser, Overload Protection Function
Cost Effective. Low capital outlay, minimal maintenance requirements and proven lower running costs compared to other waste disposal units/pan flushers makes the Vortex the obvious choice for any budget.
Main cost saving factors: average of 60% less water usage per item than traditional pan washers; lower electricity requirements; minimal maintenance required; staff is free to spend more time with patients
Environmentally friendly. Average of 60% less water usage per item than traditional pan washers; two minute cycle using only cold water; approximately 97% less electricity required compared to pan washers which maintain minimum water temperature of 85°C; products are completely macerated and biodegradable; the Vortex does not create aerosols in the process and there is no need to use detergents or chemicals
Durability and Efficiency. The twin blades allow complete maceration; the Vortex is durable – average life span 10 years; it is manufactured to ISO EN 9001:2000; it is easy to clean – designed to withstand detergents and disinfectants. Technical Support – trained engineers/spare parts readily available; comprehensive manual for sites with in-house engineers.
OH&S Benefits. The Vortex cycle will only begin when the lid is securely latched and it cannot be opened accidentally while in use. Carefully designed start control locks mean that the machine will automatically cut out in the unlikely event of a blockage or insufficient water in the macerator. An overload protection function and malfunction warning light are integral safety features. No steam, no splashing from sluicing. No chemicals required. More hygienic – no pans/bottles waiting to be cleaned.
These are all the reasons why so many flagship hospitals around Australia are already experiencing the benefits of the Vernacare system of macerator and pulp containers.
Watch the Vortex macerator in action in our video at www.eboshealthcare.com.au.
For more information on Vortex and the Vernacare disposal system contact EBOS Healthcare at 1800 269 534 or email [email protected]
26 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 27
HEALTHLINES ISSUE #4
VernacareSystem.indd 1 30/07/12 12:56 PM
28 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]
a
De’Ann Keevers – National Equipment Co-ordinatorDe’Ann has over twenty years’ experience in the Healthcare Industry, eighteen of which have been
working with EBOS, selling EBOS Healthcare products.
De’Ann started with Tasmanian Medical Supplies where she specialised in Aged Care. She was instrumental in the promotion of the EBOS Macerator System into the Tasmanian aged care market and
soon proved herself as an expert in this area.
Later on De’Ann moved to Queensland as the Territory Business Manager for Invacare and spent five years in the role. This allowed her to continue to support the aged care market. She built extremely good business
relationships and gained considerable experience with the diverse aged care product range.
During the past two years in Queensland De’Ann worked as “Business Development Manager for Novis Healthcare and this was the catalyst for her passion for Pressure Care, which she lovingly refers to as “her baby”.
With the addition of two beautiful grandsons into her family, De’Ann has just re-located back to Tasmania and re-joined EBOS Healthcare.
She is extremely happy to be back with EBOS in the new role of “National Equipment Co-ordinator”. This is a perfect fit with her speciality in supporting our Aged Care and Hospital Sales Team using “Solution focused, team oriented leadership”.
De’Ann is dedicated to ensuring our customers receive unsurpassed service at all times. Her main goal is to help EBOS Healthcare consolidate their position as “One Stop Shop” for all medical consumables and equipment for the Hospital and Aged
Care markets.
FREE 4 WEEKS SUPPLY OF PRODUCT
VERNACARE BEDPAN & SUPPORT
FREE 4 WEEKS SUPPLY OF PRODUCT
VERNACARE VERNATRAY
Contact your IP Account Manager for details on this trial offer or email [email protected]
THE BEST WAY TO TRIAL THESE NEW VERNACARE PRODUCTS
